Endothelial Dysfunction in COVID-19: Potential Mechanisms and Possible Therapeutic Options
SARS-CoV-2, a novel coronavirus found in Wuhan (China) at the end of 2019, is the etiological agent of the current pandemic that is a heterogeneous disease, named coronavirus disease 2019 (COVID-19). SARS-CoV-2 affects primarily the lungs, but it can induce multi-organ involvement such as acute myoc...
Main Authors: | Maria Chiara Pelle, Isabella Zaffina, Stefania Lucà, Valentina Forte, Vincenzo Trapanese, Melania Melina, Federica Giofrè, Franco Arturi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-10-01
|
Series: | Life |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-1729/12/10/1605 |
Similar Items
-
Potential Role of Glucagon-like Peptide-1 Receptor Agonists in the Treatment of Cognitive Decline and Dementia in Diabetes Mellitus
by: Maria Chiara Pelle, et al.
Published: (2023-07-01) -
Endothelial dysfunction in the first trimester of pregnancy
by: Alexey V. Mironov, et al.
Published: (2020-07-01) -
Effect of dual glucose-dependent insulinotropic peptide/glucagon-like peptide-1 receptor agonist on weight loss in subjects with obesity
by: Isabella Zaffina, et al.
Published: (2023-02-01) -
Semaglutide and kidney function: friends or enemies?
by: Federica Giofrè, et al.
Published: (2024-02-01) -
A role of endothelial dysfunction in development of maternal, perinatal and pediatric morbidity
by: A. V. Mironov, et al.
Published: (2020-11-01)